Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumors Meeting Abstract


Authors: Doz, F.; van Tilburg, C. M.; Geoerger, B.; Nysom, K.; Øra, I.; Boni, V.; Chisholm, J.; Chung, H. C.; DuBois, S. G.; Melcón, S. G.; Gerber, N. U.; Goto, H.; Grilley-Olsen, J. E.; Hansford, J. R.; Hong, D. S.; Italiano, A.; Kang, H. J.; Capra, M.; Schulte, J. H.; Stefanowicz, J.; Tahara, M.; Ziegler, D. S.; Gavrilovic, I. T.; Norenberg, R.; Dima, L.; De La Cuesta, E.; Laetsch, T. W.; Drilon, A.; Perreault, S.
Abstract Title: Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumors
Meeting Title: 26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 23
Issue: Suppl. 6
Meeting Dates: 2021 Nov 18-21
Meeting Location: Boston, MA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2021-11-01
Start Page: vi73
End Page: vi74
Language: English
ACCESSION: WOS:000757356200285
PROVIDER: wos
DOI: 10.1093/neuonc/noab196.283
Notes: Meeting Abstract: CTNI-58 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    633 Drilon